1. Home
  2. VIRT vs DNTH Comparison

VIRT vs DNTH Comparison

Compare VIRT & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtu Financial Inc.

VIRT

Virtu Financial Inc.

N/A

Current Price

$68.72

Market Cap

6.0B

Sector

Finance

ML Signal

N/A

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

N/A

Current Price

$111.10

Market Cap

6.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VIRT
DNTH
Founded
2008
2015
Country
United States
United States
Employees
1027
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.5B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
VIRT
DNTH
Price
$68.72
$111.10
Analyst Decision
Hold
Strong Buy
Analyst Count
5
13
Target Price
$45.60
$121.00
AVG Volume (30 Days)
1.3M
718.6K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
1.89%
N/A
EPS Growth
72.73
N/A
EPS
3.62
N/A
Revenue
$3,632,118,000.00
$2,036,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.34
$29.48
P/E Ratio
$16.90
N/A
Revenue Growth
26.25
N/A
52 Week Low
$31.55
$22.81
52 Week High
$68.02
$117.88

Technical Indicators

Market Signals
Indicator
VIRT
DNTH
Relative Strength Index (RSI) 69.40 54.51
Support Level $55.11 $79.27
Resistance Level N/A $114.55
Average True Range (ATR) 3.13 5.11
MACD 0.94 -0.55
Stochastic Oscillator 93.92 42.67

Price Performance

Historical Comparison
VIRT
DNTH

About VIRT Virtu Financial Inc.

Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: